Detection of sentinel lymph node metastases in endometrial cancer: Performance evaluation of the OSNA assay

Detection of sentinel lymph node metastases in endometrial cancer: Performance evaluation of the OSNA assay - Performance evaluation of the OSNA assay

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018083

Enrollment

240

Registered

2015-06-25

Start date

2015-02-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cancer

Interventions

Using OSNA assay, we perform the performance evaluation of sentinel lymph node metastatic diagnosis in endometrial cancer.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Endometrial cancer

Exclusion criteria

Exclusion criteria: 1)lymph node metastasis and distant metastasis at their preoperative evaluation with magnetic resonance imaging(MRI) and/or computed tomography(CT) 2)history of treatment of radiotherapy and/or chemotherapy 3)history of treatment of uterine adnexectomy 4)an allergic medical history of RI and/or blue dye 5)ovarian metastasis and serosa invasion at their preoperative evaluation with MRI and/or CT.

Design outcomes

Primary

Measure	Time frame
Concordance between the OSNA assay and histopathological examination	—

Countries

Japan

Contacts

Public ContactSatoshi Okamoto

Tohoku University Hospital gynecology

s-okamoto@med.tohoku.ac.jp022-717-7254

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026